-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Aspirin, as one of the three classic drugs in the history of medicine, has a history of hundreds of years since its clinical application, and is still a good medicine for antipyretic, analgesic and anti-inflammatory drugs
.
With the development of medicine, many studies have found that aspirin can reduceHeart blood vessels occurrence of an event, for ages 50--59 years old at high risk for cardiovascular disease, guidelines have been used as a cardiovascular disease prevention
Aspirin, as one of the three classic drugs in the history of medicine, has a history of hundreds of years since its clinical application, and is still a good medicine for antipyretic, analgesic and anti-inflammatory drugs
pixabay
pixabayStudies have shown that diabetic patients suffering from CVD risk in patients with non-diabetic 2 Dao 4 times, but the role of aspirin in primary prevention in people with diabetes is unclear
.
Recently, a study published in the journal JAMA Netw Open explored the use of aspirin in elderly people with and without diabetes in the United States
Studies have shown that diabetic patients suffering from diabetic patients suffering from diabetes, CVD risk of non-diabetic patients with 2 Dao 4 CVD risk in patients with non-diabetic 2 Dao 4 times, but the role of aspirin in primary prevention in people with diabetes is unclear
The study used nationally representative data from the National Health and Nutrition Examination Survey from2011 to 2018 .
A total of 7103 Ming 60 years or older diabetics and non-diabetic patients completed a questionnaire on prophylactic aspirin use .
The use of prophylactic aspirin was defined as the use of low-dose aspirin by participants based on doctor’s recommendation or self-decision .
Statistical analysis time is 2019 Nian 7 Yue 1 to 2021 Nian 4 Yue 1 Ri .
The results of the study showed that a total of 7103 participants 60 years of age or older were included , of which 45.
2% were men and 75.
8% were white
The results of the study showed that a total of 7103 participants 60 years of age or older were included , of which 45.
2% were men and 75.
Among people who do not have cardiovascular disease but have diabetes, those who take aspirin are also more likely to be men.
Those who take aspirin are also more likely to be men , and the average waist circumference (mean [SD] , 110.
Aspirin use in different age groups and cardiovascular disease (CVD) status among elderly people with and without diabetes
Aspirin use in different age groups and cardiovascular disease (CVD) status among elderly people with and without diabetesAmong people without cardiovascular disease and diabetes, the average age of aspirin users is higher (using aspirin, 70.
2[0.
In people without cardiovascular disease and diabetes, the average age of aspirin users is higher (using aspirin, and in people without cardiovascular disease and diabetes, the average age of aspirin users is 70.
Association of age, gender and cardiovascular disease with aspirin for primary or secondary prevention
Association of age, gender and cardiovascular disease with aspirin for primary or secondary preventionIn the logistic regression model, after adjusting for age, race / ethnicity, gender, education, CVD risk, and BMI , diabetes was significantly associated with a significantly higher chance of using aspirin
.
Among people with diabetes, there is no difference in the likelihood of using aspirin for primary or secondary prevention between high-risk and low-risk groups
In the logistic regression model, after adjusting for age, race / ethnicity, gender, education, CVD risk, and BMI , diabetes was significantly associated with a significantly higher chance of using aspirin
In summary, the possibility of the United States, the use of aspirin in patients with diabetes than non-primary prevention of diabetes high in the United States, the possibility of using aspirin for diabetics than non-primary prevention of diabetes 1 times
.
Women are significantly less likely to use aspirin than men, especially in diabetic patients
.
In people without diabetes, the older the age, the more likely it is to use aspirin
.
It is even more necessary for healthcare providers to ask their elderly patients about the use of aspirin, and in view of recent changes in the guidelines, discuss the risks and benefits of continuing aspirin therapy to prevent cardiovascular disease
.
1 times
.
Women are significantly less likely to use aspirin than men, especially in diabetic patients
.
In people without diabetes, the older the age, the more likely it is to use aspirin
.
It is even more necessary for healthcare providers to ask their elderly patients about the use of aspirin, and in view of recent changes in the guidelines, discuss the risks and benefits of continuing aspirin therapy to prevent cardiovascular disease
.
Original source
Original sourceElizabeth Y.
Liu, BA1; Mohammed E.
Al-Sofiani, MBBS, MSc1,2 ; Hsin-Chieh Yeh, PhD3,4,5 ; et al.
Use of Preventive Aspirin Among Older US Adults With and Without Diabetes .
JAMA Netw Open .
2021;4(6):e2112210.
doi:10.
1001/jamanetworkopen.
2021.
12210
Liu, BA1; Mohammed E.
Al-Sofiani, MBBS, MSc1,2 ; Hsin-Chieh Yeh, PhD3,4,5 ; et al.
Use of Preventive Aspirin Among Older US Adults With and Without Diabetes .
JAMA Netw Open .
2021;4(6):e2112210.
doi:10.
1001/jamanetworkopen.
2021.
12210 Mohammed E.
Al-Sofiani, MBBS, MSc1,2 Hsin-Chieh Yeh, PhD3,4,5 Use of Preventive Aspirin Among Older US Adults With and Without Diabetes leave a message here